Abstract
The aim was to investigate how the PI3K/Akt pathway is involved in the protection of dexmedetomidine against propofol. The hippocampal neurons from fetal rats were separated and cultured in a neurobasal medium. Cell viability was assayed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Then neurons were pretreated with different concentrations of dexmedetomidine before 100 μmol/L propofol was added. Akt, phospho-Akt (p-Akt), Bad, phospho-Bad (p-Bad), and Bcl-xL were detected by Western blot. Also, neurons were pretreated with dexmedetomidine alone or given the inhibitor LY294002 before dexmedetomidine pretreatment, and then propofol was added for 3 h. The results demonstrated that propofol decreased the cell viability and the expression of p-Akt and p-Bad proteins, increased the level of Bad, and reduced the ratio of Bcl-xL/Bad. Dexmedetomidine pretreatment could reverse these effects. The enhancement of p-Akt and p-Bad induced by dexmedetomidine was prevented by LY294002. These results showed that dexmedetomidine potently protected the developing neuron and this protection may be partly mediated by the PI3K/Akt pathway.
中文概要
目的
研究PI3K/Akt 信号通路是否参与了右美托咪定 对异丙酚诱导的胎鼠海马神经元凋亡的保护作 用,并初步探讨可能的作用机制。
创新点
首次利用胎鼠海马神经元研究发现右美托咪定对 异丙酚诱导的神经元凋亡作用部分是由 PI3K/Akt 信号通路介导的。
方法
首先分离胎鼠海马神经元并鉴定。使用MTT 法 检测异丙酚对神经元活性的影响。然后将神经元 分为不同的组,分别用0.1、1、10 和100 μmol/L 右美托咪定预处理细胞,然后加入100 μmol/L 的异丙酚继续培养,同时设异丙酚组和正常对照 组。使用蛋白质印迹(Western blot)方法检测 Akt、p-Akt、Bad、p-Bad 和Bcl-xL 的表达变化。 在100 μmol/L 右美托咪定预处理前加入 LY294002,进一步研究PI3K/Akt 途径是否参与 了右美托咪定对异丙酚诱导的胎鼠海马神经元 凋亡的保护作用。
结论
实验结果显示,异丙酚明显降低了神经元的细胞 活性及p-Akt 和p-Bad 的表达水平,增加了Bad 的表达,从而Bcl-xL/Bad 的比率升高。100 μmol/L 右美托咪定预处理可以逆转这种效果。 LY294002 可以抑制右美托咪定的保护作用,说 明右美托咪定对异丙酚诱导的胎鼠海马神经元 凋亡的保护作用部分是由PI3K/Akt 信号通路介 导的。
Similar content being viewed by others
References
Bhana, N., Goa, K.L., McClellan, K.J., 2000. Dexmedetomidine. Drugs, 59(2):263–270. http://dx.doi.org/10.2165/00003495-200059020-00012
Cai, Y., Xu, H., Yan, J., et al., 2014. Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury. Mol. Med. Rep., 9(5):1542–1550. http://dx.doi.org/10.3892/mmr.2014.2034
Cantley, L.C., 2002. The phosphoinositide 3-kinase pathway. Science, 296(5573):1655–1657. http://dx.doi.org/10.1126/science.296.5573.1655
Cattano, D., Young, C., Straiko, M.M., et al., 2008. Subanesthetic doses of propofol induce neuroapoptosis in the infant mouse brain. Anesth. Analg., 106(6):1712–1714. http://dx.doi.org/10.1213/ane.0b013e318172ba0a
Clancy, B., Darlington, R.B., Finlay, B.L., 2001. Translating developmental time across mammalian species. Neuroscience, 105(1):7–17. http://dx.doi.org/10.1016/S0306-4522(01)00171-3
Creeley, C., Dikranian, K., Dissen, G., et al., 2013. Propofolinduced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. Br. J. Anaesth., 110(Suppl. 1):i29–i38. http://dx.doi.org/10.1093/bja/aet173
Degos, V., Charpentier, T.L., Chhor, V., et al., 2013. Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression. Anesthesiology, 118(5):1123–1132. http://dx.doi.org/10.1097/ALN.0b013e318286cf36
Duan, X., Li, Y., Zhou, C., et al., 2014. Dexmedetomidine provides neuroprotection: impact on ketamine-induced neuroapoptosis in the developing rat brain. Acta Anaesthesiol. Scand., 58(9):1121–1126. http://dx.doi.org/10.1111/aas.12356
Ikonomidou, C., Bosch, F., Miksa, M., et al., 1999. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science, 283(5398):70–74. http://dx.doi.org/10.1126/science.283.5398.70
Ikonomidou, C., Bittigau, P., Ishimaru, M.J., et al., 2000. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science, 287(5455):1056–1060. http://dx.doi.org/10.1126/science.287.5455.1056
Ikonomidou, C., Bittigau, P., Koch, C., et al., 2001. Neurotransmitters and apoptosis in the developing brain. Biochem. Pharmacol., 62(4):401–405. http://dx.doi.org/10.1016/S0006-2952(01)00696-7
Irifune, M., Takarada, T., Shimizu, Y., et al., 2003. Propofolinduced anesthesia in mice is mediated by γ-aminobutyric acid-A and excitatory amino acid receptors. Anesth. Analg., 97(2):424–429. http://dx.doi.org/10.1213/01.ANE.0000059742.62646.40
Jauniaux, E., Gulbis, B., Shannon, C., et al., 1998. Placental propofol transfer and fetal sedation during maternal general anaesthesia in early pregnancy. Lancet, 352(9124): 290–291. http://dx.doi.org/10.1016/S0140-6736(05)60265-6
Jevtovic-Todorovic, V., Hartman, R.E., Izumi, Y., et al., 2003. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci., 23(3):876–882.
Karen, T., Schlager, G.W., Bandix, I., et al., 2013. Effect of propofol in the immature rat brain on short-and long-term neurodevelopmental outcome. PLoS ONE, 8(5):e64480. http://dx.doi.org/10.1371/journal.pone.0064480
Li, J., Xiong, M., Nadavaluru, P.R., et al., 2016. Dexmedetomidine attenuates neurotoxicity induced by prenatal propofol exposure. J. Neurosurg. Anesth., 28(1):51–64. http://dx.doi.org/10.1097/ANA.0000000000000181
Li, Y., Zeng, M., Chen, W., et al., 2014. Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats. PLoS ONE, 9(4):e93639. http://dx.doi.org/10.1371/journal.pone.0093639
Liao, Z., Cao, D., Han, X., et al., 2014. Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats. Brain Res. Bull., 107:69–78. http://dx.doi.org/10.1016/j.brainresbull.2014.07.001
Nguyen, H.T., Li, K.Y., da Graca, R.L., et al., 2009. Behavior and cellular evidence for propofol-induced hypnosis involving brain glycine receptors. Anesthesiology, 110(2): 326–332. http://dx.doi.org/10.1097/ALN.0b013e3181942b5b
Ngwenyama, N.E., Anderson, J., Hoernschemeyer, D.G., et al., 2008. Effects of dexmedetomidine on propofol and remifentanil infusion rates during total intravenous anesthesia for spine surgery in adolescents. Paediatr. Anaesth., 18(12):1190–1195. http://dx.doi.org/10.1111/j.1460-9592.2008.02787.x
Orrei, M.G., Catizone, L., Pavlica, P., et al., 1986. Radiologic surveillance of uremic osteodystrophy after parathyroidectomy. Radiol. Med., 72(7-8):521–752.
Pan, W., Lin, L., Zhang, N., et al., 2016. Neuroprotective effects of dexmedetomidine against hypoxia-induced nervous system injury are related to inhibition of NF-κB/COX-2 pathways. Cell. Mol. Neurobiol., 36(7): 1179–1188. http://dx.doi.org/10.1007/s10571-015-0315-2
Paris, A., Mantz, J., Tonner, P.H., et al., 2006. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the α2A-adrenoceptor subtype. Anesth. Analg., 102(2):456–461. http://dx.doi.org/10.1213/01.ane.0000194301.79118.e9
Pesic, V., Milanovic, D., Tanic, N., et al., 2009. Potential mechanism of cell death in the developing rat brain induced by propofol anesthesia. Int. J. Dev. Neurosci., 27(3):279–287. http://dx.doi.org/10.1016/j.ijdevneu.2008.12.005
Ramsay, M.A., Luterman, D.L., 2004. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology, 101(3): 787–790. http://dx.doi.org/10.1097/00000542-200409000-00028
Sanders, R.D., Maze, M., 2007. α2-Adrenoceptor agonists. Curr. Opin. Investig. Drugs, 8(1):25–33.
Sanders, R.D., Sun, P., Patel, S., et al., 2010. Dexmedetomidine provides cortical neuroprotection: impact on anaestheticinduced neuroapoptosis in the rat developing brain. Acta Anaesthesiol. Scand., 54(6):710–716. http://dx.doi.org/10.1111/j.1399-6576.2009.02177.x
Schoeler, M., Loetscher, P.D., Rossaint, R., et al., 2012. Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury. BMC Neurol., 12:20. http://dx.doi.org/10.1186/1471-2377-12-20
Taniguchi, T., Kidani, Y., Kanakura, H., et al., 2004. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit. Care Med., 32(6):1322–1326. http://dx.doi.org/10.1097/01.CCM.0000128579.84228.2A
Workman, A.D., Charvet, C.J., Clancy, B., et al., 2013. Modeling transformations of neurodevelopmental sequences across mammalian species. J. Neurosci., 33(17):7368–7383. http://dx.doi.org/10.1523/JNEUROSCI.5746-12.2013
Xiong, B., Shi, Q.Q., Miao, C.H., 2014. Dexmedetomidine renders a brain protection on hippocampal formation through inhibition of nNOS-NO signalling in endotoxininduced shock rats. Brain Inj., 28(7):1003–1008. http://dx.doi.org/10.3109/02699052.2014.888765
Yin, C., Guo, L.S., Liu, Y., et al., 2011. Repeated administration of propofol upregulated the expression of c-Fos and cleaved-caspase-3 proteins in the developing mouse brain. Indian J. Pharmacol., 43(6):648–651.
Yu, D., Jiang, Y., Gao, J., et al., 2013. Repeated exposure to propofol potentiates neuroapoptosis and long-term behavioral deficits in neonatal rats. Neurosci. Lett., 534:41–46. http://dx.doi.org/10.1016/j.neulet.2012.12.033
Yuen, V.M., 2010. Dexmedetomidine: perioperative applications in children. Paediatr. Anaesth., 20(3):256–264. http://dx.doi.org/10.1111/j.1460-9592.2009.03207.x
Zhang, X., Wang, J., Qian, W., et al., 2014. Dexmedetomidine inhibits tumor necrosis factor-alpha and interleukin 6 in lipopolysaccharide-stimulated astrocytes by suppression of c-Jun N-terminal kinases. Inflammation, 37(3):942–949. http://dx.doi.org/10.1007/s10753-014-9814-4
Author information
Authors and Affiliations
Corresponding author
Additional information
The two authors contributed equally to this work
Project supported by the Medical and Health Technology Development Program in Shandong Province (No. 2015WSA13033) and the National Natural Science Foundation of China (No. 81301114)
Rights and permissions
About this article
Cite this article
Zhang, N., Su, Qp., Zhang, Wx. et al. Neuroprotection of dexmedetomidine against propofol-induced neuroapoptosis partly mediated by PI3K/Akt pathway in hippocampal neurons of fetal rat. J. Zhejiang Univ. Sci. B 18, 789–796 (2017). https://doi.org/10.1631/jzus.B1600476
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B1600476